ZMAR represents the Innovator Equity Defined Protection ETF – 1 Yr March, a U.S.-listed exchange-traded fund issued by Innovator Capital Management. This ETF falls into the defined outcome category, where the aim is to provide exposure to S&P 500 large-cap returns up to a set cap while buffering against the full downside of the underlying index over a one-year period.
The investment objective of ZMAR centers on matching the upside price return of the SPDR S&P 500 ETF Trust (SPY), up to a predetermined cap, while offering a buffer against 100% of SPY's losses during the annual outcome period from March 1 through February 28. Before fees and expenses, the fund targets full protection from any decline in the reference ETF within that window.
Unlike standard index ETFs, ZMAR is actively managed and does not follow a traditional index. It primarily holds FLEX Options referencing SPY, which allows the construction of a specific capped-upside and buffered-downside profile. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the defined-outcome space.
Launched on February 28, 2025, by Innovator Capital Management, the fund has a net expense ratio of 0.79%. Holdings tend to feature the VOO Vanguard S&P 500 ETF as a core position along with the FLEX options that implement the buffer and cap. Sector exposure generally aligns with the S&P 500, led by information technology, followed by financials, communication services, and health care.
Investors are drawn to ZMAR for its balance between equity participation and capital preservation. The key feature is the downside buffer, which is structured to shield against all losses of the reference ETF over the full one-year period, before fees. This can appeal to those concerned about volatility or looking to moderate risk without exiting equities.
The main trade-off remains the upside cap, which limits gains in strong markets and resets each year. From what I see, this positions the fund as a defensive complement in a broader portfolio, providing measured market participation through an options-based approach rather than direct ownership. As a result, it typically does not distribute dividends and focuses on total return potential.
Several factors warrant attention with ZMAR. The 100% buffer is effective only for the complete one-year outcome period, so buying or selling mid-period can lead to different results, including potential losses. The upside cap also means the fund may underperform the S&P 500 during strong rallies.
Other considerations include concentration in S&P 500 sectors, possible tracking differences relative to the reference ETF, and the effect of the 0.79% expense ratio over time. The fund is non-diversified, and options usage introduces counterparty and liquidity elements. Defined-outcome structures are complex, so reviewing the prospectus remains essential to grasp how the buffer and cap operate in practice.
Tickeron's AI Screener helps me quickly compare defined-outcome ETFs like ZMAR against peers by applying technical, fundamental, and volatility filters. This tool has become a regular part of my process for identifying funds that align with specific risk parameters without sifting through dozens of options manually.
ZMAR offers a structured way to gain U.S. large-cap equity exposure alongside a one-year downside buffer, accepting a capped upside in return. Its design provides a distinct option for investors focused on preservation while maintaining some participation in market gains. As with any such vehicle, suitability depends on aligning the fund’s risk-return profile with individual objectives, time frames, and comfort with complexity.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.
ZMAR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 17 instances where the indicator turned negative. In 2 of the 17 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 12%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ZMAR as a result. In 2 of 21 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 10%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZMAR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 10%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +0.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZMAR advanced for three days, in 18 of 122 cases, the price rose further within the following month. The odds of a continued upward trend are 15%.
ZMAR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 29 of 235 cases where ZMAR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 12%.